Diabetes Care, Vol 16, Issue 2 462-468, Copyright © 1993 by American Diabetes Association

ARTICLES

Regional cerebral blood flow and cerebrovascular reactivity in IDDM

G Rodriguez, F Nobili, MA Celestino, S Francione, G Gulli, K Hassan, S Marenco, G Rosadini and R Cordera
Department of Motor Science-Neurophysiopathology, University of Genova, Italy.

OBJECTIVE--To investigate both rCBF and cerebrovascular reactivity, evaluated as pre- and post-ACZ rCBF differences in a group of IDDM patients with differences in duration of disease and severity of complications. RESEARCH DESIGN AND METHODS--rCBF was measured by the 133Xenon inhalation method in 20 IDDM patients and in 15 healthy control subjects before and after an intravenous injection of ACZ, a carbonic anhydrase inhibitor commonly used to assess cerebrovascular reactivity. RESULTS--Basal global CBF (the mean of 32 regional values) was within the normal range in all patients but 1, who showed slight hyperperfusion; moreover, in 3 patients with long-lasting disease, some hypoperfused regions were found. ANOVA showed an inverse correlation between basal global CBF (P < 0.01) and duration of diabetes, but no correlation with Hb, MABP, serum glucose concentration, or GHb. Compared with control subjects, the percentage of global CBF increment after ACZ administration was significantly impaired in 4 patients and gave a borderline response in 2 patients; 4 of these poor ACZ responders had retinopathy, and 1 had suffered from a TIA. Duration of diabetes, Hb, MABP, serum glucose concentration, and GHb did not correlate with the percentage of post-ACZ global CBF changes, and did not differ among the 6 poor ACZ responders and the other diabetic patients or control subjects. CONCLUSIONS--These results confirm that global CBF is within the normal range in most IDDM patients, although it is significantly influenced by the duration of diabetes; pathophysiological correlates of the altered cerebrovascular reactivity need to be further investigated. rCBF measurements, before and after ACZ administration, seem to represent a safe and reliable tool for assessing cerebrovascular function in IDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF]

				B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels Brain Imaging in Patients With Diabetes: A systematic review. Diabetes Care, November 1, 2006; 29(11): 2539 - 2548. [Full Text] [PDF]

				A. F. van Raamt, A. P. A. Appelman, W. P. T. M. Mali, Y. van der Graaf, and For the SMART Study Group Arterial Blood Flow to the Brain in Patients with Vascular Disease: The SMART Study. Radiology, August 1, 2006; 240(2): 515 - 521. [Abstract] [Full Text] [PDF]

				Y. Kadoi, S. Saito, F. Goto, and N. Fujita The Effect of Diabetes on the Interrelationship Between Jugular Venous Oxygen Saturation Responsiveness to Phenylephrine Infusion and Cerebrovascular Carbon Dioxide Reactivity Anesth. Analg., August 1, 2004; 99(2): 325 - 331. [Abstract] [Full Text] [PDF]

				Th. Karapanayiotides, B. Piechowski-Jozwiak, G. van Melle, J. Bogousslavsky, and G. Devuyst Stroke patterns, etiology, and prognosis in patients with diabetes mellitus Neurology, May 11, 2004; 62(9): 1558 - 1562. [Abstract] [Full Text] [PDF]

				Y. Kadoi, H. Hinohara, F. Kunimoto, S. Saito, M. Ide, H. Hiraoka, F. Kawahara, and F. Goto Diabetic Patients Have an Impaired Cerebral Vasodilatory Response to Hypercapnia Under Propofol Anesthesia Stroke, October 1, 2003; 34(10): 2399 - 2403. [Abstract] [Full Text] [PDF]

				C. Tantucci, P. Bottini, C. Fiorani, M. L. Dottorini, F. Santeusanio, L. Provinciali, C. A. Sorbini, and G. Casucci Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy J Appl Physiol, March 1, 2001; 90(3): 889 - 896. [Abstract] [Full Text] [PDF]

				K. Y. Lee, Y. H. Sohn, J. S. Baik, G. W. Kim, and J.-S. Kim Arterial Pulsatility as an Index of Cerebral Microangiopathy in Diabetes Stroke, May 1, 2000; 31(5): 1111 - 1115. [Abstract] [Full Text] [PDF]